Clinical Trial Update: A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ONCOS-102 in combination with durvalumab in advanced peritoneal malignancies (colorectal, ovarian, and appendiceal cancers) completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer
• Ovarian Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• ONCOS-102

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Colorectal Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-12-22